Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing muscle responses for monitoring neuromuscular function after surgery

Official title: Comparison of Adductor Pollicis and Abductor Digiti Minimi Muscles (Thumb Vs. Fifth Digit) As Sites for Neuromuscular Monitoring with Electromyography

Run by University of Debrecen · NCT06691204 · Data updated 2026-11-12

This study is testing a device to see if it can better monitor muscle function after surgery for patients who have received a specific muscle relaxant.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment46 (estimated)
SponsorUniversity of Debrecen
Academic / other
Locations2 sites (Debrecen, Hajdú-Bihar and 1 other locations)
StatusRecruiting
StartedOctober 18, 2024
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedNovember 15, 2024
Trial IDNCT06691204 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older undergoing elective surgeries that require neuromuscular blocking agents.

Probably not a fit

Patients with neuromuscular disorders, significant organ dysfunction, or those undergoing surgeries that involve prepping the arm into the sterile field may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the TetraGraph device in monitoring two muscle groups, the adductor pollicis and the abductor digiti minimi, to assess neuromuscular blockade and recovery following the use of rocuronium during elective surgeries. It aims to identify differences in muscle sensitivity to neuromuscular blocking agents and reversal agents by measuring electrical activity in these muscles through electromyography. The study addresses challenges in monitoring due to patient positioning and involuntary movements, providing a potentially reliable method for detecting residual neuromuscular blockade in postoperative patients.

Why it matters

Potential benefit: If successful, this study could improve the detection of residual neuromuscular blockade, enhancing patient safety and recovery outcomes after surgery.

How similar studies have gone: While the approach of using electromyography for monitoring neuromuscular function is established, this specific comparison of muscle groups with the TetraGraph device is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> or = 18 years old
* Patients willing to participate and provide an informed consent
* Patients undergoing elective surgical procedures that require use of NMBA agents (rocuronium) administered intraoperatively.

Exclusion Criteria:

* Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
* Patients with systemic neuromuscular diseases such as myasthenia gravis.
* Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal impairment or end-stage liver disease.
* Patients having surgery that would involve prepping the arm into the sterile field.
* Patients receiving a rapid sequence induction.
* Patients allergic to rocuronium or sugammadex.

Where it's running

  • University of Debrecen, Department of Anesthesiology and Intensive Care
    Debrecen, Hajdú-Bihar, Hungary
    Recruiting
  • University of Debrecen, Debrecen, Hajdú-Bihar 4008
    Debrecen, Hungary
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.